Know Cancer

or
forgot password
  • cancer clinical trials in new brunswick, NJ

  • The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
    UMDNJ - Robert Wood Johnson University Hospital
    New Brunswick, New Jersey 08903
    Childhood Hepatocellular Carcinoma, Papillary Thyroid Cancer, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Thyroid Cancer, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Selumetinib and Akt Inhibitor MK2206 in Treating Patients With Stage III or Stage IV Melanoma Who Failed Prior Therapy With Vemurafenib or Dabrafenib
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
    Cancer Center of NJ
    New Brunswick, New Jersey 08901
    Melanoma
    Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
    UMDNJ - Robert Wood Johnson University Hospital
    New Brunswick, New Jersey 08903
    Neurofibromatosis Type 1, Recurrent Childhood Pilocytic Astrocytoma, Recurrent Childhood Visual Pathway Glioma
    Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
    UMDNJ - Robert Wood Johnson University Hospital
    New Brunswick, New Jersey 08903
    Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
    UMDNJ - Robert Wood Johnson University Hospital
    New Brunswick, New Jersey 08903
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Diffuse Large Cell Lymphoma, L3 Childhood Acute Lymphoblastic Leukemia, Stage III Childhood Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Untreated Childhood Acute Lymphoblastic Leukemia
    Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors
    Cancer Institute of New Jersey Dept of Cancer Institute of NJ
    New Brunswick, New Jersey 08901
    Advanced Solid Tumors, Excluding Breast Cancer
    Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer or Metastatic Large Cell Neuroendocrine Non-Small Cell Lung Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Extensive Stage Small Cell Lung Cancer, Large Cell Lung Cancer, Metastatic Carcinoma of Unknown Primary, Neuroendocrine Carcinoma, Newly Diagnosed Carcinoma of Unknown Primary
    A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
    UMDNJ/Robert Wood Johnson
    New Brunswick, New Jersey 08903
    Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
    Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Non-small Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer
    Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Breast Cancer
    Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
    UMDNJ Robert Wood Johnson, Medical School Division
    New Brunswick, New Jersey 08901
    Psoriasis, Psoriatic Arthritis
    A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Resectable Pancreatic Cancer
    Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
    Call for Information (Investigational Site 0027)
    New Brunswick, New Jersey 08901
    Malignant Melanoma
    Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Breast Cancer, HER2-negative Breast Cancer
    Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Multiple Myeloma
    A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
    Site Reference ID/Investigator# 89595
    New Brunswick, New Jersey 08901
    Oncology, BRCA Mutated, High Grade Serous Ovarian Cancer, BRCA Mutated Breast Cancer
    RSSearch Registry-Long Term Study of Use of SRS/SBRT to Treat Tumors and Other Functional Diseases
    St. Peter's University Hospital
    New Brunswick, New Jersey 08901
    Neoplasms, Arteriovenous Malformations, Trigeminal Neuralgia
    Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Lung Cancer
    Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Prostate Cancer
    Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Kidney Cancer
    Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Breast Cancer
    Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Metastatic Cancer
    Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Leukemia
    Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
    Saint Peter's University Hospital
    New Brunswick, New Jersey 08901-1780
    Leukemia
    Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Breast Cancer
    Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Leukemia
    Combination Chemotherapy in Treating Children With Progressive Brain Tumors
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    Brain and Central Nervous System Tumors
    Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Desmoid Tumor
    Combination Chemotherapy in Treating Children With Neuroblastoma
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Neuroblastoma
    Surgery in Treating Children With Neuroblastoma
    Cancer Institute of New Jersey at Robert Wood Johnson University Hospital
    New Brunswick, New Jersey 08903
    Neuroblastoma
    Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Breast Cancer, Metastatic Cancer, Pain, Prostate Cancer
    Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Leukemia
    Fenretinide in Treating Children With Solid Tumors
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Vinorelbine in Treating Children With Recurrent or Refractory Cancers
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Brain and Central Nervous System Tumors, Neuroblastoma, Sarcoma
    Methylphenidate in Treating Patients With Melanoma
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    Ifosfamide in Treating Patients With Meningeal Tumors
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Chondrosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Rhabdomyosarcoma, Adult Malignant Meningioma, Adult Brain Malignant Hemangiopericytoma
    Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer
    Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer
    Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Breast Cancer
    Irofulven in Treating Children With Recurrent or Refractory Solid Tumors
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Unspecified Childhood Solid Tumor, Protocol Specific
    Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Brain and Central Nervous System Tumors
    Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
    Cancer Institute of New Jersey at Robert Wood Johnson University Hospital
    New Brunswick, New Jersey 08903
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Colorectal Cancer
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Melanoma (Skin)
    Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Lung Cancer
    Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Gestational Trophoblastic Tumor
    Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Sarcoma
    Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Leukemia
    O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Brain and Central Nervous System Tumors
    Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Leukemia
    Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Head and Neck Cancer
    Eflornithine in Treating Patients With Bladder Cancer
    Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Bladder Cancer
    Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Diarrhea, Radiation Enteritis
    Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Esophageal Cancer
    PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Prostate Cancer
    Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Lung Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Breast Cancer
    Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia
    Cancer Institute of New Jersey

    Trial Locations
    Cancer Institute of New Jersey
    Saint Peter's University Hospital
    Leukemia
    12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Precancerous/Nonmalignant Condition